A randomized trial of fenretinide in superficial bladder cancer: 20 year follow-up and prognostic significance of VEGF.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e15500-e15500
Author(s):  
Marilena Petrera ◽  
Matteo Puntoni ◽  
Sara Campora ◽  
Carlotta Defferrari ◽  
Rosalba Torrisi ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Trial ◽  
Superficial Bladder Cancer ◽  
Prognostic Significance

832: Optimized Intravesical Mitomycin C Treatment for Superficial Bladder Cancer: Long-Term Follow-Up

2006 ◽  
Vol 175 (4S) ◽  
pp. 268-269 ◽  
Author(s):  
Jessie L. Au ◽  
Robert A. Badalament ◽  
M. Guillaume Wientjes ◽  
Donn C. Young ◽  
Tong Shen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Mitomycin C ◽  
Superficial Bladder Cancer ◽  
Long Term Follow Up

A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer

1994 ◽  
Vol 35 (S1) ◽  
pp. S31-S35 ◽  
Author(s):  
Kikuo Okamura ◽  
Tatsuro Murase ◽  
Koji Obata ◽  
Shinichi Ohshima ◽  
Yoshinari Ono ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Randomized Trial ◽  
Superficial Bladder Cancer ◽  
Intravesical Instillation

Prognostic Significance of ABH Antigenicity of Mucosal Biopsies in Superficial Bladder Cancer

1986 ◽  
Vol 136 (6) ◽  
pp. 1194-1196 ◽  
Author(s):  
G. Das ◽  
N.J.C. Buxton ◽  
P.A. Hamilton Stewart ◽  
R.W. Glashan
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Prognostic Significance

596 UROVYSION© VS TRADITIONAL SURVEILLANCE FOR FOLLOW–UP OF PATIENTS WITH SUPERFICIAL BLADDER CANCER

2007 ◽  
Vol 6 (2) ◽  
pp. 171 ◽  
Author(s):  
S. Gudjonsson ◽  
B.L. Isfoss ◽  
K. Hansson ◽  
A.M. Domanski ◽  
J. Warenholt ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Traditional Surveillance

scholarly journals The value of the NMP22 test for superficial bladder cancer diagnosis and follow-up

2014 ◽  
Vol 39 (3) ◽  
pp. 137-142 ◽  
Author(s):  
Caner Dogan ◽  
Eyyüp Sabri Pelit ◽  
Asif Yildirim ◽  
Itir Ebru Zemheri ◽  
Cengiz Canakci ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Cancer Diagnosis ◽  
Superficial Bladder Cancer

scholarly journals Expression and prognostic significance of LIVIN, SURVIVINand other apoptosis-related genes in the progression of superficial bladder cancer

2003 ◽  
Vol 14 (1) ◽  
pp. 85-90 ◽  
Author(s):  
P. Gazzaniga ◽  
A. Gradilone ◽  
L. Giuliani ◽  
O. Gandini ◽  
I. Silvestri ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Prognostic Significance

Espressione di oncogeni di proliferazione e morte cellulare nel carcinoma superficiale della vescica: Expression of oncogenes in relation to cell proliferation and death in superficial bladder carcinoma

1995 ◽  
Vol 62 (2) ◽  
pp. 216-228
Author(s):  
G. Ferrari ◽  
G. Castagnetti ◽  
A. Dotti ◽  
G. Galizia ◽  
P. Ferrari ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Superficial Bladder Cancer ◽  
Neoplastic Progression ◽  
P53 Expression ◽  
Proliferation Indices ◽  
Superficial Bladder Carcinoma ◽  
Progression Of Disease ◽  
The One ◽  
Definition Of

Although superficial bladder cancer may be considered “benign”, it is still today a many-sided neoplasm with a prognosis that cannot be well-defined with known traditional parameters. Proliferation indices Ki67 and AgNOR associated with the expression of some oncogenes (p53, Rb, c-myc, BCL2, c-erbB-2) in relation to traditional parameters could help in the prognosis definition of individual patients. 111 patients with superficial bladder cancer were studied for this purpose, relating the grade, stage, follow-up and morphotype to the proliferation indices. Significant correlations were found with AgNOR, but only for grade with Ki67. The study of the oncoproteins and their different expression showed that those alterations typical of infiltration are already present in the superficial forms, with a significant correlation between oncogenic alterations and grade and stage of disease (p53, Rb) on the one hand, and above all of disease-free interval and progression (c-erbB-2) on the other. Lastly, assessment of the oncoproteins c-myc and BCL2, oncogenes connected with the programmed cell death mechanism (apoptosis), showed important correlations with the neoplastic progression of disease in relation to the p53 expression and proliferative activity.

Sign in / Sign up

Export Citation Format

Share Document